Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Structure Therapeutics will present at three New York healthcare investor conferences, with live and archived webcasts available on its investor relations site.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Structure Therapeutics (GPCR) will participate in three healthcare investor conferences in September 2026, featuring fireside chats and 1x1 meetings.
Events include the Cantor Global Healthcare Conference on Thursday, September 10 (3:55–4:25 PM EDT), the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16 (10:45–11:20 AM EDT), and Bernstein’s 3rd Annual Healthcare Forum on Wednesday, September 23 (3:00–3:40 PM EDT), all in New York, NY. Live and archived webcasts will be available on the company’s investor relations website for at least 90 days.
Details
News Market Reaction – GPCR
On Sep 3, the day this news came out, GPCR closed 0.96% below the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Upcoming conferences
- 3 conferences
- September 2026
- Cantor conference date
- September 10, 2026
- Cantor Global Healthcare Conference
- Morgan Stanley conference date
- September 16, 2026
- Morgan Stanley 24th Annual Global Healthcare Conference
- Bernstein forum date
- September 23, 2026
- Bernstein’s 3rd Annual Healthcare Forum
- Meetings format
- 1x1 meetings
- Each of the three healthcare events
- Replay availability
- 90 days
- Webcast replays
Historical Context
-
Reported Q2 results, Phase 3 dosing, and liquidity expected through 2028
-
Reported statistically significant weight loss and planned Phase 3 initiation
-
Announced two June healthcare conferences with fireside chats and meetings
-
Reported Phase 2 data, FDA feedback, and planned Phase 3 initiation
-
Announced clinical and preclinical presentations at ADA scientific sessions
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September:
2026 Cantor Global Healthcare Conference
Date: Thursday, September 10
Format: Fireside chat and 1x1 meetings
Time: 3:55 – 4:25 PM EDT
Location: New York, NY
Morgan Stanley 24th Annual Global Healthcare Conference
Date: Wednesday, September 16
Format: Fireside chat and 1x1 meetings
Time: 10:45 – 11:20 AM EDT
Location: New York, NY
Bernstein’s 3rd Annual Healthcare Forum
Date: Wednesday, September 23
Format: Fireside Chat and 1x1 meetings
Time: 3:00 – 3:40 PM EDT
Location: New York, NY
The live and archived webcasts will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for at least 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more people living with obesity around the world. For additional information, please visit www.structuretx.com.
Investors:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com
Jennifer Robinson
Structure Therapeutics Inc.
jennifer.robinson@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.